NCT03655015 Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
| NCT ID | NCT03655015 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center at San Antonio |
| Condition | Lung Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2018-10-16 |
| Primary Completion | 2028-12-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Create a living biobank of PDOs from Stage I-III lung cancer patients.
Eligibility Criteria
Inclusion Criteria: * Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure. * Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care * Any clinical stage of lung cancer * Adult patients ≥18 years of age * Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history Exclusion Criteria: * At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.